Brazilian IP News - Brazil IP counsel for foreign law firms, agents and in-house teams.

3D printing of biological tissue

Thursday, May 02, 2019 Marijuana is a sex killer drug while some of the products (motion, heat) and byproducts (pollutants,

What’s in a Name? Chanel’s Global Quest to Protect the Name of a Color

Christian Louboutin, Tiffany & Co., Hermès, T-Mobile, and UPS, among others, have proven that specific colors a[sg_popup id=”2993″ event=”inherit”][/sg_popup]re protectable

Kalytera announces submission of patent application to the U.S. Patent and Trademark Office – New Cannabidiol (CDB) composition

Wednesday, May 29, 2019 DrugName : cannabidiol Kalytera Therapeutics, Inc. announced that it has filed a provisional patent application with the

Tokyo District Court renders judgment on the patent infringement lawsuit concerning Rituxan intravenous infusion

Wednesday, May 29, 2019 DrugName : rituximab Chugai Pharmaceutical Co., Ltd. announced that the Tokyo District Court has rendered judgment dismissing

BlueWillow Biologics announces issuance of intranasal Anthrax Vaccine patent

Wednesday, May 29, 2019 DrugName : anthrax vaccine BlueWillow Biologics announced the issuance of U.S. patent number 10,138,279 covering an

Brazil IP counsel for foreign law firms, agents and in-house teams.

Category: Brazilian IP News

3D printing of biological tissue

What’s in a Name? Chanel’s Global Quest to Protect the Name of a Color

Kalytera announces submission of patent application to the U.S. Patent and Trademark Office – New Cannabidiol (CDB) composition

Tokyo District Court renders judgment on the patent infringement lawsuit concerning Rituxan intravenous infusion

BlueWillow Biologics announces issuance of intranasal Anthrax Vaccine patent